Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Oxybate for Sleep and Daytime Functioning in Chronic Fatigue Syndrome
NCT02055898Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Apr 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium oxybate in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), sponsored by Imperial College London. Started Apr 2014; status: completed.
02
Drugs
sodium oxybate
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT02055898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02055898.